A new study in the American Journal of Preventive Medicine highlights the continued success and impact the FDA’s “The Real Cost” campaign has had on youth smoking initiation.
Read more: Statement on new results demonstrating continued success of the agency’s youth smoking prevention efforts and significant public health cost savings